Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Mead Johnson Must Face Enfamil NEC Lawsuit in Missouri State Court Judge rejected the infant formula manufacturer’s attempt to remove an Illinois mother’s NEC lawsuit to the federal court system. July 8, 2025 Irvin Jackson Add Your Comments The U.S. District Judge presiding over all NEC lawsuits brought against the manufacturers of Enfamil and Similac has rejected an attempt by Mead Johnson to remove an Illinois woman’s claim to the federal court system, indicating that case will be returned to the Missouri state courts, where it was originally filed. Mead Johnson and Abbott Laboratories face hundreds of Enfamil lawsuits and Similac lawsuits brought by families nationwide, each involving similar allegations that the infant formula manufacturers failed to warn parents and the medical community about the risk that premature babies may develop necrotizing enterocolitis (NEC) after they are fed the cow’s milk products. NEC is a serious and life-threatening complication, which occurs when harmful bacteria infiltrates the walls of a newborn’s intestines, causing portions of the tissue to become inflamed or die. In many cases, infants who develop NEC from infant formula require emergency surgery while still in the neonatal intensive care unit (NICU), and many newborns do not survive NEC. Although there has been evidence for decades that cow’s milk-based infant formula products increase the risk of NEC for premature babies, lawsuits allege that the manufacturers have aggressively marketed their products for use among these vulnerable infants, providing false and misleading information that minimized the benefits of human breast milk. BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Most of the lawsuits brought by families of premature babies diagnosed with NEC are currently pending in the federal court system, where U.S. District District Judge Rebecca R. Pallmeyer is presiding over a federal multidistrict litigation (MDL), which is centralized in the Northern District of Illinois for coordinated discovery and pretrial proceedings. However, some claims have been brought directly in various different state courts nationwide. Enfamil Lawsuit Remand Motions Cadence Collins originally filed her complaint (PDF) in the Circuit Court for the City of St. Louis, Missouri in July 2024, indicating that her child, identified with the initials K.H., developed NEC from Enfamil. Defendants named in the case included both Mead Johnson and a local sales representative, Jessica Mackey, who is a resident of Missouri. Shortly after the case was brought, Mead Johnson filed a Notice of Removal (PDF), transferring the claim to the federal court system, where it was subsequently consolidated with other federal Similac and Enfamil NEC lawsuits pending before Judge Pallmeyer. However, Collins fought the removal, arguing that the case was properly filed in Missouri state court, noting that there is a lack of diversity required to establish federal jurisdiction, since Mackey is a resident of Missouri. Mead Johnson claimed that the inclusion of Mackey was a “fraudulent joinder,” which was only meant to keep the case in state court. However, Pallmeyer issued a memorandum opinion and order (PDF) on July 3, agreeing that the inclusion of Mackey was a tactical one, but determining that it was sufficient to allow the case to move forward in Missouri state court. “Plaintiff’s decision to include Mackey as a defendant in this action and not other cases arising from Missouri may well be, in Plaintiff’s counsel’s words, ‘strategic’ and for ‘jurisdictional’ reasons. But the court’s analysis under fraudulent joinder is an objective one, looking only to whether Plaintiff has a ‘reasonable possibility of success’ against the non-diverse defendant. Further developments in this litigation, such as a failure by Plaintiff to prosecute the case against Mackey, may provide a new basis for a finding of fraudulent joinder.” -Judge Rebecca R. Pallmeyer, Memorandum Opinion and Order On the same day the Court returned Collins’ case to state court, Judge Pallmeyer issued another order (PDF) denying similar efforts by a group of six plaintiffs who filed their claims in Pennsylvania state court. All six claims were filed on March 24, 2022, against Mead Johnson, Abbott and the hospitals where the infants were born. Those local hospital defendants were subsequently dismissed from the lawsuit, which the manufacturers argued established federal jurisdiction. Judge Pallmeyer agreed, noting that the defendants could now remove all but one of those six claims to her court. Infant Formula NEC Lawsuits July 2025 Update To help the parties gauge how federal juries may respond to certain evidence and testimony that is likely to be repeated throughout hundreds of claims brought by parents across the U.S., Judge Pallmeyer is currently preparing a series of bellwether lawsuits for early trial dates in the federal MDL. The first bellwether trial is currently scheduled to begin on August 8, involving a NEC lawsuit filed by a Maryland mother, Keosha Diggs, who indicates that her child developed the condition after being fed both Similac and Enfamil. A second bellwether trial is already planned, involving claims brought by Alexis Inman, whose child died after being fed Mead Johnson’s Enfamil products shortly after birth. No trial date has yet been set, but dispositive motions have been given an August 25 deadline, with responses due by September 22, and replies due by October 6, 2025. The bellwether cases will be closely watched, since the average payouts awarded by juries in these early trials will likely have a substantial impact on the amount that Abbott and Mead Johnson may be required to pay in NEC formula lawsuit settlements, to avoid hundreds of additional claims going before juries. To stay up to date on this litigation, sign up to receive Infant Formula NEC lawsuit updates sent directly to your inbox. Tags: Abbott Laboratories, Enfamil, Infant Death, Infant Formula, Mead Johnson, Necrotizing Enterocolitis, Preterm Birth Find Out If You Qualify for Infant Formula NEC Compensation Written By: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior legal and investigative journalist with more than 30 years of experience covering complex issues at the intersection of law, politics, and environmental policy. He began his reporting career in 1991 after graduating from Wayne. More Baby Formula Stories Similac NEC Settlement Talks Result in MDL Census Order for Filed and Unfiled Claims July 24, 2025 NEC Formula Lawsuit Set To Go Before Jury in Aug. 2025 June 23, 2025 Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ June 17, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Problems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (Posted: yesterday) Hologic, Inc. faces a BioZorb tissue marker lawsuit filed by two Montana women who say the implants failed to absorb properly into their bodies. MORE ABOUT: BIOZORB LAWSUITLawyers Preparing BioZorb Lawsuit To Go Before Jury on Sept. 8, 2025 (07/23/2025)Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (07/07/2025)BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025) Judge Orders Cartiva Implant Settlement Talks Before Trial in Aug. 2026 (Posted: yesterday) The first Cartiva toe implant trial has been delayed until August 2026, with parties ordered to engage in settlement negotiations. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Settlement Rumors Mount Again, as More Toe Implant Lawsuits Withdrawn and Trials Approach (06/26/2025)Failed Cartiva Implant Resulted in Need for Removal, Big Toe Fusion Surgery: Lawsuit (04/10/2025)Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (03/31/2025) Depo-Provera MDL Judge Pushes for Meningioma Lawsuits To Be Filed Quicker (Posted: 4 days ago) A federal judge has ordered plaintiffs’ attorneys involved in Depo-Provera meningioma lawsuits to reveal how many claims remain unfiled. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Diagnosis Resulted in Invasive Brain Surgery, Lawsuit Alleges (07/21/2025)Over 550 Depo-Provera Lawsuits Being Pursued by Women With Meningioma Brain Tumors (07/15/2025)Depo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (07/11/2025)
Problems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (Posted: yesterday) Hologic, Inc. faces a BioZorb tissue marker lawsuit filed by two Montana women who say the implants failed to absorb properly into their bodies. MORE ABOUT: BIOZORB LAWSUITLawyers Preparing BioZorb Lawsuit To Go Before Jury on Sept. 8, 2025 (07/23/2025)Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (07/07/2025)BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)
Judge Orders Cartiva Implant Settlement Talks Before Trial in Aug. 2026 (Posted: yesterday) The first Cartiva toe implant trial has been delayed until August 2026, with parties ordered to engage in settlement negotiations. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Settlement Rumors Mount Again, as More Toe Implant Lawsuits Withdrawn and Trials Approach (06/26/2025)Failed Cartiva Implant Resulted in Need for Removal, Big Toe Fusion Surgery: Lawsuit (04/10/2025)Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (03/31/2025)
Depo-Provera MDL Judge Pushes for Meningioma Lawsuits To Be Filed Quicker (Posted: 4 days ago) A federal judge has ordered plaintiffs’ attorneys involved in Depo-Provera meningioma lawsuits to reveal how many claims remain unfiled. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Diagnosis Resulted in Invasive Brain Surgery, Lawsuit Alleges (07/21/2025)Over 550 Depo-Provera Lawsuits Being Pursued by Women With Meningioma Brain Tumors (07/15/2025)Depo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (07/11/2025)